Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：12.8 Date：2025-05-13

Biomaterials

Orally-deliverable liposome-microgel complexes dynamically remodel intestinal environment to enhance probiotic ulcerative colitis therapy via TLR4 inhibition and tryptophan metabolic crosstalk

Products： ELK8136
IF：12.771 Date：2021-06-15

Journal of Biomedical Science

Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency

Products： ELK1190、 ELK1270、 ELK8145、 ELK8727
IF：12.6 Date：1970-01-01

Journal of Nanobiotechnology

A two-stage transdermal drug delivery system comprising sono-phase-change transfersomes for non-invasive deep dermal delivery

Products： SA002
IF：12.5 Date：2025-07-18

Science Advances

Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease

Products： ELK8229

< Page of 486 >